{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:43:34Z","timestamp":1760100214470},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T00:00:00Z","timestamp":1303084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> The aim of this study was to evaluate changes in the anterior chamber depth (ACD) in primary open\u2010angle glaucoma (POAG) patients during latanoprost therapy.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> We carried out a prospective study in which we enrolled 66 newly diagnosed POAG patients treated with latanoprost 0.005% (group 1) and 50 ocular hypertensive and\/or glaucoma suspect cases who were given no therapy (group 2 [control]). Measurements of the ACD were performed by A\u2010scan ultrasonography before and after cycloplegia at baseline and at 3\u2003months of latanoprost therapy. Differences in ACD and their correlations with the ocular hypotensive effect of the agent as well as the clinical significance of changes in ACD were analysed using Student\u2019s <jats:italic>t<\/jats:italic>\u2010test and Pearson\u2019s correlation coefficient. Statistical significance was set at p\u2003&lt;\u20030.05.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Mean baseline ACD was 3.13\u2003\u00b1\u20030.35\u2003mm (range 2.45\u20133.84\u2003mm) in group 1 and 3.14\u2003\u00b1\u20030.36\u2003mm (range 2.54\u20133.80\u2003mm) in group 2 (p\u2003=\u20030.89). At 1\u2003hour after instillation of cyclopentolate 1%, mean ACD in groups 1 and 2 was 3.18\u2003\u00b1\u20030.38\u2003mm (range 2.45\u20133.92\u2003mm) and 3.19\u2003\u00b1\u20030.37\u2003mm (range 2.56\u20133.91\u2003mm), respectively (p\u2003=\u20030.91). After 3\u2003months of treatment, mean ACD in group 1 both without (3.05\u2003\u00b1\u20030.36\u2003mm, range 2.14\u20133.76\u2003mm) and with (3.09\u2003\u00b1\u20030.4\u2003mm, range 2.20\u20133.96\u2003mm) cycloplegia was significantly reduced compared with baseline values (p\u2003&lt;\u20030.001 for both). However, there was no significant difference between mean ACD at baseline and that at month\u20033 in group 2. No correlation was demonstrated between the changes in ACD and the ocular hypotensive effect of latanoprost (p\u2003=\u20030.96, <jats:italic>r<\/jats:italic>\u2003=\u2003\u2212\u20030.006). There were no changes in refractive status or visual acuity.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The overall results seem to suggest that latanoprost decreases mean ACD in patients with POAG. The clinical significance of this effect is uncertain.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2009.01683.x","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T14:59:24Z","timestamp":1256655564000},"page":"274-277","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alterations in anterior chamber depth in primary open\u2010angle glaucoma patients during latanoprost therapy"],"prefix":"10.1111","volume":"89","author":[{"given":"Ali Bulent","family":"Cankaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Teberik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golge","family":"Acaroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4,18]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3400171"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.11.1312"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(03)00243-8"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0014"},{"key":"e_1_2_5_6_1","first-page":"900","article-title":"Anterior chamber depth measurement with A\u2010scan ultrasonography, Orbscan II, and IOLMaster","volume":"82","author":"Hashemi H","year":"2005","journal-title":"Optom Vis Sci"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0058"},{"key":"e_1_2_5_8_1","first-page":"2214","article-title":"Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro","volume":"38","author":"Kashiwagi K","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/9780203007204.015"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.4A6267.2004"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200308000-00002"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.21491"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00847.x"},{"key":"e_1_2_5_14_1","first-page":"2461","article-title":"Prostaglandin F2 alpha effects on isolated rhesus monkey ciliary muscle","volume":"36","author":"Poyer JF","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.6.794"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00994.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(01)01214-7"},{"key":"e_1_2_5_18_1","first-page":"716","article-title":"Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost","volume":"43","author":"Weinreb RN","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"e_1_2_5_19_1","first-page":"43","article-title":"Effects of prostaglandins on the aqueous humour outflow pathways","volume":"47","author":"Weinreb RN","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0413"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713680590968222"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2009.01683.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2009.01683.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:42:15Z","timestamp":1697373735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2009.01683.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,18]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1755-3768.2009.01683.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01683.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,18]]},"assertion":[{"value":"2011-04-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}